Lv53
1010 积分 2021-07-28 加入
Advances in Primary Central Nervous System Lymphoma
2小时前
已完结
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago‐gastric Diseases (PROCEED): A single‐arm phase 2 trial
21小时前
已完结
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
23小时前
已完结
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
1天前
待确认
Unraveling survival disparities in primary central nervous system (CNS) lymphoma: an analysis of race, socioeconomic factors, and treatment outcomes using the surveillance, epidemiology, and end results program (2000–2021)
1天前
已完结
Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomas
1天前
待确认
Stereotactic radiosurgery for central nervous system lymphoma: a systematic review and meta-analysis
1天前
待确认
Meta‐analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma
1天前
已完结
Diagnostic, Pathologic, and Therapeutic Considerations for Primary CNS Lymphoma
4天前
已完结
Radiotherapy in primary central nervous system lymphoma: Evolution of its role and current position in combined treatment strategies
5天前
已完结
皖公网安备34019202002308
